DRUG Operating Cash Flow Growth
Bright Minds Biosciences Inc · Operating Cash Flow Growth
DRUG Operating Cash Flow Growth
Year-over-year change vs the same period a year earlier
Latest reported-216.97%period ending
DRUG TTM Cash from Operations YoY % (-2437.97% → -216.97%)
Year-over-year change
High-resolution chart · PNG
DRUG operating cash flow growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow Growth |
|---|---|
| -216.9708% | |
| -384.8085% | |
| -415.8835% | |
| -369.77% | |
| -205.1522% | |
| 7.4311% | |
| 51.3284% | |
| 73.6601% | |
| 67.5119% | |
| 51.1802% | |
| 54.1348% | |
| 48.302% | |
| 42.5528% | |
| 34.329% | |
| 3.5914% | |
| -85.6341% | |
| -169.3991% | |
| -549.9041% | |
| -1,406.181% | |
| -2,437.9695% |